Background:
KRAS inhibitors, including Sotorasib and Adagrasib, have expanded treatment options for patients with KRAS-mutated non small cell lung cancer (NSCLC). However, cardiovascular outcomes after KRAS inhibitor initiation remain poorly characterized.
Hypothesis:
We hypothesized that cardiovascular events...
Amal Youssef, Cecilia Villa Etchegoyen, Sherif Ahmed et al.· Circulation· 0 citations
Sodium–glucose cotransporter-2 inhibitors (SGLT2i) improve outcomes across several cardiometabolic conditions, but their role in World Health Organization group 1 pulmonary arterial hypertension (PAH) remains uncertain. We conducted a retrospective, single-center cohort study of adults with group 1 PAH. Patients prescr...
Abdelrahman Hafez, Amal Youssef, Mohamed Nour et al.· Mayo Clinic Proceedings: Inn...· 0 citations
A higher RAR was associated with abnormal LVGLS, HF hospitalization, and all-cause mortality after adjustment for clinical risk factors, but the RAR did not provide discriminative value beyond its individual components.
Sherif Ahmed, K. Awad, Abdelrahman Hafez et al.· Journal of Personalized Medi...· 0 citations
Chronological age is a dominant determinant of cardiovascular risk prediction. However, DNA methylation-derived epigenetic clocks capture biological aging processes that may reflect cumulative cardiometabolic and inflammatory exposures. Whether biological age improves contemporary cardiovascular risk estimation,...
R. Ibrahim, B. Tamarappoo, K. Lee et al.· European Heart Journal· 0 citations
Major adverse cardiovascular events (MACE) remain the leading cause of mortality worldwide. Opportunistic screening using routinely acquired clinical data offers a scalable approach for identifying high-risk individuals before acute events occur. Although chest X-rays (CXRs) capture latent cardiovascular biomarkers and...
Biologic PREVENT variants were associated with mortality but did not improve discrimination compared with chronologic PREVENT, suggesting biological aging metrics may complement rather than replace chronological age in cardiovascular risk prediction.
Ramzi Ibrahim, B. Tamarappoo, Kwan S. Lee et al.· Circulation. Population heal...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.